Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $46,656 | $50,088 | $63,207 | $33,112 |
| - Cash | $15,197 | $16,087 | $15,108 | $17,964 |
| + Debt | $10,238 | $10,341 | $10,441 | $20,572 |
| Enterprise Value | $41,698 | $44,342 | $58,539 | $35,720 |
| Revenue | $8,292 | $10,837 | $11,713 | $10,436 |
| % Growth | -23.5% | -7.5% | 12.2% | – |
| Gross Profit | $7,304 | $8,826 | $10,287 | $8,459 |
| % Margin | 88.1% | 81.4% | 87.8% | 81.1% |
| EBITDA | -$796 | $699 | $2,734 | $46 |
| % Margin | -9.6% | 6.5% | 23.3% | 0.4% |
| Net Income | -$1,941 | -$741 | $1,257 | -$1,904 |
| % Margin | -23.4% | -6.8% | 10.7% | -18.2% |
| EPS Diluted | -0.13 | -0.05 | 0.08 | -0.14 |
| % Growth | -160% | -162.5% | 157.1% | – |
| Operating Cash Flow | $187 | $844 | $3,899 | $1,905 |
| Capital Expenditures | -$24 | -$26 | -$48 | -$27 |
| Free Cash Flow | $163 | $817 | $3,851 | $1,878 |